NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

Shree Ganesh Remedies

BSE: 540737 21 Feb 2025
Healthcare
₹ 746.0
Shree Ganesh Remedies Limited specializes in Pharmaceuticals within the Healthcare sector.

Shree Ganesh Remedies - Share Price & Details

Market Cap
₹958.0
High /Low
950.0 / 558.0
Stock P/E
32.9
Book Value
₹104.0
Dividend Yield
0.0
ROCE
27.8
ROE
₹26.9
Face Value
10.0
PEG Ratio
0.94
EVEBITDA
₹19.9
Debt
33.8
CMP / FCF
-82.8
Debt to equity
₹0.25
NP Ann
28.1
High price all time
950.0
Piotroski score
₹8.0
Graham Number
230.0
No. Eq. Shares
1.28
Net CF
₹7.12
Net profit
29.1
Price to book value
7.17
Interest Coverage
₹31.3
Low price all time
22.1
Industry PE
29.9
Reserves
₹120
Free Cash Flow
₹-0.69

Price Chart


Volume Chart


Peer Comparison

Stock Net Sales EPS P/E
Shyama Computronics and Servic0.61NA30.9
Triochem Products Ltd.,NA3.60
Shree Ganesh Remedies Limited270.534.2232.9
KOPRAN LTD.719.381.5319.5
Shukra Pharmaceuticals Limited105.840.72104.0

Peer Comparison Chart


About Shree Ganesh Remedies

Shree Ganesh Remedies Limited, with Security Code 540737, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Motisons Jewellers standalone net profit rises 100.77% in the September 2024 quarter

(23 Nov 2024)
Net profit of Motisons Jewellers rose 100.77% to Rs 10.40 crore in the quarter ended September 2024 as against Rs 5.18 crore during the previous quarter ended...
Read more →

Cyclophosphamide Market Is Booming So Rapidly with Chemocare, We

(20 Nov 2024)
The latest research report on the Cyclophosphamide Market examines investments in this sector, highlighting how companies are implementing...
Read more →

5 high-growth stocks that turned attractive the past week

(05 Nov 2024)
The Indian stock market continued its downward trend the past week (October 28-November 4), with BSE Sensex and BSE Midcap falling 2 per...
Read more →

5 high-growth stocks that got hot the past week

(05 Nov 2024)
The Indian stock market continued its downward trend the past week (October 28-November 4), with BSE Sensex and BSE Midcap falling 2 per...
Read more →

Shree Ganesh Remedies standalone net profit declines 1.98% in the September 2024 quarter

(30 Oct 2024)
Net profit of Shree Ganesh Remedies declined 1.98% to Rs 6.42 crore in the quarter ended September 2024 as against Rs 6.55 crore during the previous quarter...
Read more →

Shree Ganesh Re Standalone September 2024 Net Sales at Rs 32.33 crore, down 3.24% Y-o-Y

(30 Oct 2024)
Quarterly Net Profit at Rs. 6.42 crore in September 2024 down 2.11% from Rs. 6.55 crore in September 2023. EBITDA stands at Rs. 11.49 crore...
Read more →